Immunoparesis in IgM gammopathies as a useful biomarker to predict disease progression

  • Marcio Andrade-Campos, Ilda Murillo-Flórez, Ramón García-Sanz, Pilar Giraldo
  • Clinical Chemistry and Laboratory Medicine (CCLM), January 2017, De Gruyter
  • DOI: 10.1515/cclm-2016-0748

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Prof Pilar Giraldo